Current Report Filing (8-k)
January 18 2022 - 6:29AM
Edgar (US Regulatory)
0001497130
false
0001497130
2021-01-14
2021-01-14
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
January 14, 2021
NANO
MOBILE HEALTHCARE, INC.
(Exact
Name of Registrant as Specified in its Charter)
Nevada
(State
or other jurisdiction
of incorporation)
|
000-55155
(Commission
File
Number)
|
98-0659770
(I.R.S.
Employer
Identification No.)
|
370
Amapola Avenue Suite 200-A
Torrance, CA 90501
(Address of Principal Executive Offices and Zip Code)
Registrant’s
telephone number, including area code: (424) 358-1046
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
Trading
Symbol(s)
|
Name
of each exchange on which registered
|
Common
Stock, par value of $0.00001
|
VNTH
|
OTCMKTS
|
SECTION
5 – CORPORATE GOVERNANCE AND MANAGEMENT
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of
Certain Officers.
On
January 14, the Company parted ways with Mr. David
Noah Kittle, who was previously appointed President and CEO of the Company on October 14, 2021. Mr. Kittle's
departure was not the result of any dispute or disagreement with the Company or the Company's
Board of Directors on any matter relating to the operations, policies or practices of the Company. The Company needed a jolt and change
of leadership to help it capitalize on emerging opportunities in the Web3, Gaming, Crypto and Metaverse industries. The Company has begun
a search for a new President and CEO.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
NANO
MOBILE HEALTHCARE, INC.
Date: January 14, 2022
|
By:
/s/ Frank I Igwealor
|
|
Name:
|
Frank I Igwealor, JD, MBA, CPA, CMA,
CFM, MSRM, ESQ.
|
|
Title:
|
Interim Chairman
|
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Jul 2023 to Jul 2024